OTC - PURPOSE SECTION
Used for facial whitening, moisturizing and blemish removal to maintain even and radiant skin.
Dark Spot Corrector Serum
- Manufacturer
- Guangzhou Kadiya Biotechnology Co., Ltd.
- Effective date
- 2025-02-17
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 00:55:52
Label at a glance#
ProductDark Spot Corrector Serum
Active ingredientNIACINAMIDE, GLUTATHIONE
Label structure9 sections
Label contents#
Full prescribing information#
INACTIVE INGREDIENT SECTION
AQUA，PROPYLENE GLYCOL，GLYCERETH-26，GLYCERIN，PENTAERYTHRITYL TETRAETHYLHEXANOATE， CAPRYLIC/CAPRIC TRIGLYCERIDE，TITANIUM DIOXIDE，HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE，COPOLYMER，CETEARYL ALCOHOL，XANTHAN GUM，DMDM HYDANTOIN，AROMA，CETEARYL GLUCOSIDE，SILICA，DISODIUM EDTA，ALUMINA，SORBITAN ISOSTEARATE，POLYSORBATE 60，GLYCERYL ACRYLATE/ACRYLIC ACID，COPOLYMER，PEG-90M，BUTYLENE GLYCOL，1,2-HEXANEDIOL，PVM/MA COPOLYMER，IODOPROPYNYL BUTYLCARBAMATE
WARNINGS SECTION
Warning.
1、For external use only, avoid contact with eyes when used
2、Keep out of reach of children
INACTIVE INGREDIENT SECTION
Used for facial whitening, moisturizing and blemish removal to maintain even and radiant skin.
DOSAGE & ADMINISTRATION SECTION
Cleanse your skin with warm water and pat dry apply a thin layer of our Exdlusive Brightening Serum on affected areas, gently massage your skin and let it absorb.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF REACH OF CHILDREN SECTION
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients
Glutathione1%
NIACINAMIDE4%
INDICATIONS & USAGE SECTION
Cleanse your skin with warm water and pat dry,apply a thin layer of our Exclusive Brightening Serum on affected areas, gently massage your skin and let it absorb.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Active Ingredients
Glutathione1%
NIACINAMIDE4%
Uses：
Used for facial whitening, moisturizing and blemish removal to maintain even and radiant skin.
The storage method：
Store sealed in a cool place and out of sunlight
Warning.
1、For external use only, avoid contact with eyes when used
2、Keep out of reach of children
Inactive ingredients：
AQUA，PROPYLENE GLYCOL，GLYCERETH-26，GLYCERIN，PENTAERYTHRITYL TETRAETHYLHEXANOATE， CAPRYLIC/CAPRIC TRIGLYCERIDE，TITANIUM DIOXIDE，HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE，COPOLYMER，CETEARYL ALCOHOL，XANTHAN GUM，DMDM HYDANTOIN，AROMA，CETEARYL GLUCOSIDE，SILICA，DISODIUM EDTA，ALUMINA，SORBITAN ISOSTEARATE，POLYSORBATE 60，GLYCERYL ACRYLATE/ACRYLIC ACID，COPOLYMER，PEG-90M，BUTYLENE GLYCOL，1,2-HEXANEDIOL，PVM/MA COPOLYMER，IODOPROPYNYL BUTYLCARBAMATE
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84423-073-01 | Dark Spot Corrector Serum | 100 mL in 1 BOTTLE, PUMP | CREAM, AUGMENTED | 100 | 1 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Dark Spot Corrector Serum
- GLYCERYL ACRYLATE/ACRYLIC ACID COPOLYMER (300000 CP AT 2%)
- DMDM HYDANTOIN
- EDETATE DISODIUM
- 1,2-HEXANEDIOL
- NIACINAMIDE
- AQUA
- SILICA
- IODOPROPYNYL BUTYLCARBAMATE
- PROPYLENE GLYCOL
- SORBITAN ISOSTEARATE
- METHYL VINYL ETHER AND MALEIC ANHYDRIDE COPOLYMER (1100000 WAMW)
- POLYSORBATE 60
- PEG-90M
- BUTYLENE GLYCOL
- XANTHAN GUM
- CETEARYL GLUCOSIDE
- GLYCERETH-26
- PENTAERYTHRITYL TETRAETHYLHEXANOATE
- GLUTATHIONE
- TITANIUM DIOXIDE
- SALICYLIC ACID
- CAPRYLIC/CAPRIC TRIGLYCERIDE
- HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%)
- GLYCERIN
- CETEARYL ALCOHOL
- ALUMINA
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 84423-073 | 84423-073-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2e62f448-14c8-d154-e063-6294a90a9daa | 2e62f448-14c7-d154-e063-6294a90a9daa | 2025-02-17 | Warnings | 2e62f448-14c8-d154-e063-6294a90a9daa 2e62f448-14c7-d154-e063-6294a90a9daa |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.